These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14571156)

  • 21. Weight gain induced with olanzapine in adolescent.
    Graovac M; Ružić K; Rebić J; Dadić-Hero E; Kaštelan A; Frančišković T
    Psychiatr Danub; 2011 Mar; 23(1):101-4. PubMed ID: 21448109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
    Lieberman JA; Stroup TS; McEvoy JP; Swartz MS; Rosenheck RA; Perkins DO; Keefe RS; Davis SM; Davis CE; Lebowitz BD; Severe J; Hsiao JK;
    N Engl J Med; 2005 Sep; 353(12):1209-23. PubMed ID: 16172203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
    Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
    J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe hyperlipidemia associated with olanzapine and quetiapine use.
    Carnahan RM; Reantaso AA; Teegarden BA; Pogue T
    Am J Psychiatry; 2007 Oct; 164(10):1614-5. PubMed ID: 17898359
    [No Abstract]   [Full Text] [Related]  

  • 25. Atypical neuroleptic malignant syndrome in an adolescent.
    Rais AR; Kimmel S; Shrestha N; Rais TB; Coffey BJ
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):215-20. PubMed ID: 18439120
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute dystonia with quetiapine.
    Jonnalagada JR; Norton JW
    Clin Neuropharmacol; 2000; 23(4):229-30. PubMed ID: 11020131
    [No Abstract]   [Full Text] [Related]  

  • 27. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
    Castro-Fornieles J; Parellada M; Soutullo CA; Baeza I; Gonzalez-Pinto A; Graell M; Paya B; Moreno D; de la Serna E; Arango C
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agranulocytosis and granulocytopenia associated with quetiapine.
    Ruhé HG; Becker HE; Jessurun P; Marees CH; Heeringa M; Vermeulen HD
    Acta Psychiatr Scand; 2001 Oct; 104(4):311-3; discussion 313-4. PubMed ID: 11722307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature.
    Peritogiannis V; Tsouli S
    J Psychopharmacol; 2010 Jul; 24(7):1121-5. PubMed ID: 19395427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of metabolic and prolactin variables from a six-month randomised trial of olanzapine and quetiapine in schizophrenia.
    Bushe C; Sniadecki J; Bradley AJ; Poole Hoffmann V
    J Psychopharmacol; 2010 Jul; 24(7):1001-9. PubMed ID: 19240085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome in drug-naïve first-episode psychosis treated with atypical antipsychotics.
    Sahoo S; Ameen S; Akhtar S
    Aust N Z J Psychiatry; 2007 Jul; 41(7):629. PubMed ID: 17691161
    [No Abstract]   [Full Text] [Related]  

  • 32. How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.
    Suzuki T; Uchida H; Watanabe K; Nomura K; Takeuchi H; Tomita M; Tsunoda K; Nio S; Den R; Manki H; Tanabe A; Yagi G; Kashima H
    Psychopharmacology (Berl); 2007 Dec; 195(2):285-95. PubMed ID: 17701027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Massive increase in serum creatine kinase during olanzapine and quetiapine treatment, not during treatment with clozapine.
    Boot E; de Haan L
    Psychopharmacology (Berl); 2000 Jun; 150(3):347-8. PubMed ID: 10923763
    [No Abstract]   [Full Text] [Related]  

  • 34. Dibenzodiazepine derivative quetiapine- and olanzapine-induced chronic interstitial nephritis.
    He L; Peng Y; Fu X; Chen X; Liu H
    Ren Fail; 2013; 35(5):657-9. PubMed ID: 23560804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia.
    Peuskens J; Link CG
    Acta Psychiatr Scand; 1997 Oct; 96(4):265-73. PubMed ID: 9350955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lethal diabetic ketoacidosis in a schizophrenic patient].
    Povlsen UJ; Lublin H
    Ugeskr Laeger; 2004 Aug; 166(35):3003-4. PubMed ID: 15387013
    [No Abstract]   [Full Text] [Related]  

  • 37. Differing tolerability profiles among atypical antipsychotics.
    Hellewell JS; Haddad PM
    Am J Psychiatry; 2001 Mar; 158(3):501-2. PubMed ID: 11230007
    [No Abstract]   [Full Text] [Related]  

  • 38. Antipsychotic-associated weight gain.
    Gentile S
    Ann Pharmacother; 2004 May; 38(5):903-4. PubMed ID: 14996995
    [No Abstract]   [Full Text] [Related]  

  • 39. Olanzapine compared to quetiapine in adolescents with a first psychotic episode.
    Arango C; Robles O; Parellada M; Fraguas D; Ruiz-Sancho A; Medina O; Zabala A; Bombín I; Moreno D
    Eur Child Adolesc Psychiatry; 2009 Jul; 18(7):418-28. PubMed ID: 19198920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of atypical antipsychotic-induced weight gain in schizophrenic patients with topiramate.
    Lin YH; Liu CY; Hsiao MC
    Psychiatry Clin Neurosci; 2005 Oct; 59(5):613-5. PubMed ID: 16194268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.